SCHEMBL22100520

SCHEMBL22100520

Cc1cccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.52
TSHR P16473 4/20 0.51
ADORA2A P29274 3/20 0.51
ALOX15 P16050 2/20 0.51
ADORA3 P0DMS8 2/20 0.51
ADORA2B P29275 2/20 0.51
ADORA1 P30542 2/20 0.51
ALDH1A1 P00352 3/20 0.45
DPP4 P27487 1/20 0.43
TRPA1 O75762 1/20 0.41
MAPK1 P28482 3/20 0.41
MEN1 O00255 1/20 0.41
NTSR1 P30989 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
NR1H4 Q96RI1 1/20 0.40
CHUK O15111 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12714311 0.89 ALDH1A1 (0.56) ALDH1A1TRPA1MAPK1KMT2AGAA
SCHEMBL18780272 0.88 ALDH1A1 (0.43) L3MBTL1TSHRADORA2AALOX15ADORA3
SCHEMBL12228467 0.85 EGFR (0.51) L3MBTL1TSHRALDH1A1MAPK1MEN1
SCHEMBL17993428 0.83 L3MBTL1 (0.61) L3MBTL1TSHRADORA2AALOX15ADORA3
SCHEMBL6509217 0.82 NR1H4 (0.49) ALDH1A1MEN1KMT2ACYP1A2CLK4
SCHEMBL25107058 0.81 L3MBTL1 (0.55) L3MBTL1TSHRADORA2AALOX15ADORA3
SCHEMBL5710676 0.81 ADORA2A (0.64) L3MBTL1TSHRADORA2AALOX15ADORA3
SCHEMBL19088146 0.81 ALDH1A1 (0.37) L3MBTL1TSHRADORA2AALOX15ADORA3
SCHEMBL12202811 0.81 TSHR (0.68) L3MBTL1TSHRADORA2AALOX15ADORA3
SCHEMBL581901 0.81 ALDH1A1 (0.56) ALDH1A1TRPA1KMT2AHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017474-A1 Novel Polycyclic Compound EUTEC NEW MATERIALS TECHNOLOGY (SUZHOU) CO., LTD. (CN) 2022-01-20 US disclosed
EP-3896067-A1 NOVEL POLYCYCLIC COMPOUND Eutec New Materials Technology (Suzhou) Co., Ltd (CN) 2021-10-20 EP disclosed
WO-2020118933-A1 NOVEL POLYCYCLIC COMPOUND 优缔新材料科技(苏州)有限公司 2020-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017474-A1 Novel Polycyclic Compound CUTA, DSG1, UACA L3MBTL1 949/4885TSHR 2166/4885ADORA2A 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.